FDA Advances Key Treatments in Diabetes, Colitis, and Alzheimer’s
Healthcare providers received significant updates this week, with the US Food and Drug Administration (FDA) advancing multiple key treatments. These developments include a new application for insulin human (Afrezza) Inhalation…